Vaxxinity, Inc. (VAXX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Oct 2, 2026, 4:00 PM EST
Vaxxinity Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Quarter | Current | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| 7 | 108 | 174 | 319 | 286 | 176 | 249 | 198 | 541 | 703 | - | - | - | - | - | |
Market Cap Growth (YoY) | 175.00% | -38.95% | -30.40% | 61.20% | -47.12% | -74.91% | - | - | - | - | - | - | - | - | - |
Enterprise Value | - | 78 | 131 | 265 | 214 | 86 | 132 | 80 | 403 | 876 | - | - | - | - | - |
Last Close Price | 0.06 | 0.85 | 1.37 | 2.52 | 2.27 | 1.40 | 1.98 | 1.57 | 4.30 | 5.61 | - | - | - | - | - |
Price Ratios
Fiscal Quarter | Current | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
PS Ratio | - | - | - | - | - | - | -249469.54 | 4036.97 | 11043.19 | 10658.50 | - | - | - | - | - |
PB Ratio | 0.52 | 8.03 | 7.33 | 9.11 | 6.20 | 2.84 | 3.11 | - | 4.80 | 5.47 | - | - | - | - | - |
P/TBV Ratio | 0.52 | 8.03 | 7.33 | 9.11 | 6.20 | 2.84 | 3.11 | - | 4.80 | 5.47 | - | - | - | - | - |
EV Ratios
Fiscal Quarter | Current | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
EV/Sales Ratio | - | - | - | - | - | - | - | 1636.40 | 8215.33 | 13270.82 | - | - | - | - | - |
Financial Efficiency
Fiscal Quarter | Current | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Debt / Equity Ratio | 1.13 | 1.13 | 0.56 | 0.39 | 0.30 | 0.23 | 0.13 | - | 0.09 | 0.08 | 0.12 | 0.10 | 0.20 | -1.54 | -0.66 |
Net Debt / Equity Ratio | -1.15 | -1.15 | -1.24 | -1.21 | -1.17 | -1.17 | -1.12 | - | -1.04 | -1.05 | -0.84 | -0.91 | -0.67 | -0.29 | -0.64 |
Net Debt / EBITDA Ratio | 0.28 | 0.28 | 0.45 | 0.59 | 0.72 | 0.98 | 0.89 | - | 0.97 | 1.09 | 0.90 | 1.43 | 0.77 | -0.23 | -1.02 |
Net Debt / FCF Ratio | 0.27 | 0.27 | 0.49 | 0.72 | 0.93 | 1.25 | 1.55 | - | 1.58 | 1.64 | 1.00 | 1.40 | 0.62 | -0.20 | -1.13 |
Asset Turnover | - | - | - | - | - | - | - | - | 0 | 0.00 | - | - | - | 0.02 | - |
Inventory Turnover | - | - | - | - | - | - | - | - | - | 0.57 | - | - | - | - | - |
Quick Ratio | 1.76 | 1.76 | 2.00 | 2.38 | 2.58 | 2.83 | 3.11 | - | 5.27 | 5.33 | 2.93 | 5.07 | 3.93 | 0.80 | 0.04 |
Current Ratio | 1.89 | 1.89 | 2.15 | 2.51 | 2.78 | 3.03 | 3.33 | - | 5.46 | 5.61 | 3.39 | 5.80 | 5.27 | 0.91 | 0.07 |
Return on Equity (ROE) | -150.65% | -150.65% | -126.96% | - | -94.94% | -78.85% | -118.03% | - | -146.38% | -264.51% | - | - | - | - | - |
Return on Assets (ROA) | -48.34% | -48.34% | -46.73% | - | -41.10% | -34.78% | -49.88% | - | -67.12% | -72.11% | - | - | - | -78.00% | - |
Return on Capital Employed (ROCE) | -218.20% | -218.20% | -187.80% | -155.00% | -129.70% | -100.70% | -113.70% | - | -99.90% | -89.90% | -85.00% | -59.20% | -72.60% | -299.40% | 74.70% |
Yields
Fiscal Quarter | Current | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Earnings Yield | -816.71% | -52.85% | -38.01% | -22.61% | -26.34% | -42.62% | -41.14% | -57.51% | -22.81% | -19.50% | - | - | - | - | - |
FCF Yield | -832.59% | -53.87% | -34.87% | -18.49% | -20.20% | -32.75% | -23.35% | -34.21% | -13.73% | -11.70% | - | - | - | - | - |
Buyback Yield / Dilution | -0.45% | -0.45% | -5.61% | -19.94% | -38.68% | -64.44% | -62.55% | -39.71% | -22.73% | -16.68% | -114.91% | - | - | - | - |